2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
6
Lung Neoplasms
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Smoking Cessation
2
Recurrence
2
Neoplasm Metastasis
2
Malignant Neoplasms of Independent (Primary) Multiple Sites
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Uterine Hemorrhage
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Cessation
1
Social Stigma
1
Smoking
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Patient Participation
1
Patient Compliance
1
Ovarian Neoplasms
1
Narration
1
Multiple Myeloma
1
Metrorrhagia
1
Leukemia
1
Leiomyoma
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Health Education
1
Glioblastoma
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Prednisone
5
Mammography
5
Colonoscopy
5
Biopsy
5
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Lenalidomide
4
Biopsy, Fine-Needle
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Melphalan
3
Liquid Biopsy
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Urination
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Videotape Recording
×
Clear all
NCT05784922
2025-10-14
HOPES
Massachusetts General Hospital
Recruiting
2,000 enrolled